Science Group PLC
LSE:SAG
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
373
492
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Science Group PLC
Science Group PLC
Cash & Cash Equivalents
Science Group PLC
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Science Group PLC
LSE:SAG
|
Cash & Cash Equivalents
£41m
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Relx PLC
LSE:REL
|
Cash & Cash Equivalents
£140m
|
CAGR 3-Years
28%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
|
CLARIVATE PLC
NYSE:CLVT
|
Cash & Cash Equivalents
$357.8m
|
CAGR 3-Years
12%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
|
GlobalData PLC
LSE:DATA
|
Cash & Cash Equivalents
£188.3m
|
CAGR 3-Years
92%
|
CAGR 5-Years
63%
|
CAGR 10-Years
33%
|
|
|
Intertek Group PLC
LSE:ITRK
|
Cash & Cash Equivalents
£355.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
10%
|
CAGR 10-Years
13%
|
|
|
Alpha Financial Markets Consulting PLC
LSE:AFM
|
Cash & Cash Equivalents
£29.4m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Science Group PLC
Glance View
Science Group Plc engages in the provision of science and technology-based consultancy services. The company is headquartered in Cambridge, Cambridgeshire and currently employs 410 full-time employees. The company went IPO on 2008-07-08. The firm's segments include Services Operating Business, Product Operating Business and Freehold Properties. The Services Operating Business segment comprises two operating divisions: R&D Consultancy and Regulatory & Compliance. The Product Operating Business segment includes Frontier Smart Technologies, the third operating division. The company provides products and services to clients in the vertical markets of medical, food and beverage, industrial and consumer. The company owns two freehold properties, Harston Mill near Cambridge and Great Burgh in Epsom. Its subsidiaries include Sagentia Limited, Sagentia Technology Advisory Limited, OTM Consulting Ltd, Quadro Epsom Limited, Sagentia Inc., OTM Consulting Inc., Oakland Innovation Ltd, Leatherhead Research Limited, Technology Sciences Group Limited and SG Bidco Ltd, among others.
See Also
What is Science Group PLC's Cash & Cash Equivalents?
Cash & Cash Equivalents
41m
GBP
Based on the financial report for Jun 30, 2024, Science Group PLC's Cash & Cash Equivalents amounts to 41m GBP.
What is Science Group PLC's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
10%
Over the last year, the Cash & Cash Equivalents growth was 30%. The average annual Cash & Cash Equivalents growth rates for Science Group PLC have been 10% over the past three years , 10% over the past five years .
You don't have any saved screeners yet
